Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.260
-0.200 (-8.13%)
At close: May 22, 2026, 4:00 PM EDT
2.230
-0.030 (-1.33%)
After-hours: May 22, 2026, 7:56 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.3 million as of May 22, 2026. Its market cap has decreased by -54.09% in one year.
Market Cap
2.30M
Enterprise Value
-8.04M
1-Year Change
-54.09%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.11M to $2.30M, a decrease of -91.18%. That is a compound annual growth rate of -39.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.30M | -15.16% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.16% |
| Dec 29, 2023 | 4.76M | -39.11% |
| Dec 30, 2022 | 7.81M | -59.09% |
| Dec 27, 2021 | 19.09M | -26.88% |
| Aug 16, 2021 | 26.11M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.18M |
| Ensysce Biosciences | 3.00M |
| Calidi Biotherapeutics | 2.95M |
| Valion Bio | 2.76M |
| Oragenics | 2.56M |
| Indaptus Therapeutics | 2.38M |
| SciSparc | 2.38M |
| Bone Biologics | 2.21M |